Wei Ooi - Concepedia

Author

Wei Ooi

Princess Margaret Cancer Centre

Also Known As

W S Ooi, W. Ooi, W. S. Ooi, W.S. Ooi, Wei Keat Ooi, Wei Ooi, Wei S. Ooi, Wei Seong Ooi, WeiSeong Ooi

Publications

988

Citations

H-Index

Concepts

All Affiliations

Princess Margaret Cancer Centre Dublin City University Sunnybrook Health Science Centre National Cancer Centre Singapore National University of Singapore

About

Wei Ooi is an author at Princess Margaret Cancer Centre specializing in breast cancer, oncology, and radiation oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	309
2	Health Sciences	2	2	193
3	Orthopaedics	2	2	116
4	Pathology	1	1	62
5	Psychiatry	1	1	131

Wei Ooi

Publications

950

Citations

H-Index

Page 1

	Year	Citations
Association of proinflammatory cytokines and chemotherapy-associated cognitive impairment in breast cancer patients: a multi-centered, prospective, cohort study Yin Ting Cheung, Terence Ng, M. Shwe, Annals of Oncology	2015	235
Phase II Trial Evaluating the Palliative Benefit of Second-Line Zoledronic Acid in Breast Cancer Patients With Either a Skeletal-Related Event or Progressive Bone Metastases Despite First-Line Bisphosphonate Therapy Mark Clemons, George Dranitsaris, Wei Ooi, Journal of Clinical Oncology	2006	142
Minimal clinically important difference (MCID) for the functional assessment of cancer therapy: Cognitive function (FACT-Cog) in breast cancer patients Yin Ting Cheung, Yu Lee Foo, Maung Shwe, Journal of Clinical Epidemiology Functional AssessmentBreast OncologyPsychiatryCognitive PerformanceMedicine	2014	131
Expression of multidrug resistance markers ABCB1 (MDR-1/P-gp) and ABCC1 (MRP-1) in renal cell carcinoma Naomi Walsh, Annemarie Larkin, Susan Kennedy, BMC Urology	2009	90
A phase 2 trial exploring the effects of high‐dose (10,000 IU/day) vitamin D<sub>3</sub> in breast cancer patients with bone metastases Eitan Amir, Christine Simmons, Orit Freedman, Cancer	2009	73
Discordance between Receptor Status in Primary and Metastatic Breast Cancer: an Exploratory Study of Bone and Bone Marrow Biopsies Eitan Amir, Wei Ooi, Christine Simmons, Clinical Oncology Metastatic Breast CancerBreast OncologyReceptor StatusMedicinePathology	2008	62
Switching Breast Cancer Patients with Progressive Bone Metastases to Third-Generation Bisphosphonates: Measuring Impact Using the Functional Assessment of Cancer Therapy-Bone Pain Reuben Broom, Hongyan Du, Mark Clemons, Journal of Pain and Symptom Management Bone DiseaseFunctional AssessmentBone HealthHealth SciencesBreast Cancer Patients	2009	62
MDR1/P-glycoprotein and MRP-1 drug efflux pumps in pancreatic carcinoma. Lorraine O’Driscoll, Naomi Walsh, A. Larkin, PubMed	2007	61
A phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy Mark Clemons, George Dranitsaris, Wei Ooi, Breast Cancer Research and Treatment Bone DiseaseSurgical OncologyBreast OncologyPhase Ii TrialBreast Cancer Patients	2007	54
Membrane transport proteins in human melanoma: associations with tumour aggressiveness and metastasis Naomi Walsh, Susan Kennedy, A. Larkin, British Journal of Cancer	2010	40

Page 1